Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
Kunal Nepali, Jing‐Ping Liou
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Tazemetostat: EZH2 Inhibitor
Rachael Straining, William Eighmy
Journal of the Advanced Practitioner in Oncology (2022) Vol. 13, Iss. 2, pp. 158-163
Open Access | Times Cited: 97
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
Xuemeng Xu, Peng Qiu, Xianjie Jiang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1357-1370
Open Access | Times Cited: 93
Cancer epigenetics: from laboratory studies and clinical trials to precision medicine
Xinyang Yu, Hao Zhao, Ruiqi Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 89
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Hitesh Kumar, Neha Gupta, Rupshee Jain, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 271-292
Open Access | Times Cited: 59
Stress, diet, exercise: Common environmental factors and their impact on epigenetic age
Fedor Galkin, Olga Kovalchuk, Diana Koldasbayeva, et al.
Ageing Research Reviews (2023) Vol. 88, pp. 101956-101956
Open Access | Times Cited: 50
Beyond genetics: Exploring the role of epigenetic alterations in breast cancer
Kirti S. Prabhu, Hana Q. Sadida, Shilpa Kuttikrishnan, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155174-155174
Open Access | Times Cited: 16
Centromere inactivation during aging can be rescued in human cells
Sweta Sikder, Songjoon Baek, Truman McNeil, et al.
Molecular Cell (2025)
Open Access | Times Cited: 2
How to Slow down the Ticking Clock: Age-Associated Epigenetic Alterations and Related Interventions to Extend Life Span
Anne-Marie Galow, Shahaf Peleg
Cells (2022) Vol. 11, Iss. 3, pp. 468-468
Open Access | Times Cited: 44
Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
Soma Ghosh, Pooja A. Shah, Faye M. Johnson
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7889-7889
Open Access | Times Cited: 41
Genetics and epigenetics of chronic rhinosinusitis
Devyani Lal, Tripti Brar, Shreya P. Ramkumar, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 4, pp. 848-868
Open Access | Times Cited: 28
Epigenetic Modulators as Therapeutic Agents in Cancer
Eshaan Patnaik, Chikezie O. Madu, Yi Lü
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14964-14964
Open Access | Times Cited: 23
Restoration of epigenetic impairment in the skeletal muscle and chronic inflammation resolution as a therapeutic approach in sarcopenia
Gregory Livshits, Alexander Kalinkovich
Ageing Research Reviews (2024) Vol. 96, pp. 102267-102267
Closed Access | Times Cited: 12
Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases—Focus on Epigenetic Mechanisms
Marta Włodarczyk, Michał Ciebiera, Grażyna Nowicka, et al.
Nutrients (2024) Vol. 16, Iss. 4, pp. 559-559
Open Access | Times Cited: 8
Epigenetic Mechanisms in CRSwNP: The Role of MicroRNAs as Potential Biomarkers and Therapeutic Targets
Alkmini Gatsounia, Georgios Schinas, Gerasimos Danielides, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 114-114
Open Access | Times Cited: 1
Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy
Su Zhang, Yang Meng, Lian Zhou, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 35
Current trends in development of HDAC-based chemotherapeutics
Narges Cheshmazar, Maryam Hamzeh‐Mivehroud, Hojjatollah Nozad Charoudeh, et al.
Life Sciences (2022) Vol. 308, pp. 120946-120946
Closed Access | Times Cited: 34
The Achilles’ heel of cancer survivors: fundamentals of accelerated cellular senescence
Shameel Shafqat, Evelyn Arana Chicas, Areez Shafqat, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 13
Open Access | Times Cited: 30
Sources of Cancer Neoantigens beyond Single-Nucleotide Variants
Aude-Hélène Capietto, Reyhane Hoshyar, Lélia Delamarre
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10131-10131
Open Access | Times Cited: 30
Epigenetic regulation of cancer-associated fibroblast heterogeneity
Rachel J. Kehrberg, Namita Bhyravbhatla, Surinder K. Batra, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188901-188901
Open Access | Times Cited: 22
Epigenetics-Based Diagnostic and Therapeutic Strategies: Shifting the Paradigm in Prostate Cancer
Pier‐Luc Clermont
Epigenomics (2023) Vol. 15, Iss. 2, pp. 75-87
Closed Access | Times Cited: 19
The regulatory landscape of macrophage interferon signaling in inflammation
Ricky Siebeler, Menno P.J. de Winther, Marten A. Hoeksema
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 2, pp. 326-337
Open Access | Times Cited: 16
The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer
Marisabel Mecca, Simona Picerno, Salvatore Cortellino
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2750-2750
Open Access | Times Cited: 7
Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided Optimization
Nicolas Bauer, Dimitrios-Ilias Balourdas, Joel R. Schneider, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 2, pp. 266-279
Open Access | Times Cited: 6
Emerging Roles of SKP2 in Cancer Drug Resistance
Ting Wu, Xinsheng Gu, Hongmei Cui
Cells (2021) Vol. 10, Iss. 5, pp. 1147-1147
Open Access | Times Cited: 36
Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer
Reilly A. Sample, Marina F. Nogueira, Robi D. Mitra, et al.
Oncogene (2023) Vol. 42, Iss. 29, pp. 2237-2248
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top